Nutrition, nonalcoholic fatty liver disease and the microbiome: Recent progress in the field

Current Opinion in Lipidology

Volumn 25, Issue 1, 2014, Pages 61-66

  Vos, Miriam B ^a,b  

^a EMORY UNIVERSITY   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

diet; fructose; microbiome; nonalcoholic steatohepatitis

Indexed keywords

ALDEHYDE REDUCTASE; FRUCTOSE; GLUCOSE; OLIVE OIL; OXIDIZED LOW DENSITY LIPOPROTEIN; PALM OIL; POLYUNSATURATED FATTY ACID; SAFFLOWER OIL; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; CALORIC INTAKE; CARDIOVASCULAR RISK; CLINICAL STUDY; DISEASE SEVERITY; FATTY LIVER; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KUPFFER CELL; LIFESTYLE MODIFICATION; LIPID DIET; LIPID METABOLISM; LOW CALORY DIET; LOW FAT DIET; MALABSORPTION; MICROBIAL DIVERSITY; MICROBIOME; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITION; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WEIGHT REDUCTION;

ANIMALS; DIET; FATTY LIVER; HUMANS; LIVER; MICROBIOTA;

EID: 84893005467     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000043     Document Type: Review

References (39)

1. Armstrong MJ, Adams LA, Canbay A, Syn WK. Extra-hepatic complications of nonalcoholic fatty liver disease. Hepatology 2013. [Epub ahead of print]
2. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and nonalcoholic fatty liver disease: New insights. Clin Micro Infection 2013; 19:338-348.
3. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nat Rev Gastroenterol Hepatol 2012; 488:621-626.
4. Wigg AJ, Roberts-Thomson IC, Dymock RB, et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis. Gut 2001; 48:206-211.
5. Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49:1877-188
6. de Wit N, Derrien M, Bosch-Vermeulen H, et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol 2012; 303:G589-G59
7. Mouzaki M, Comelli EM, Arendt BM, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013; 58:120-12
8. Raman M, Ahmed I, Gillevet PM, et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013; 11:868-875.
9. Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape J Med 2008; 10:160.
10. Welsh JA, Sharma AJ, Grellinger L, Vos MB. Consumption of added sugars is decreasing in the United States. Am J Clin Nutr 2011; 94:726-734.
11. Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013; 57:2525-2531.
12. Bergheim I, Weber S, Vos M, et al. Antibiotics protect against fructoseinduced hepatic lipid accumulation in mice: Role of endotoxin. J Hepatol 2008; 48:983-992.
13. Spruss A, Kanuri G, Wagnerberger S, et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatol 2009; 50:1094-1104.
14. Kanuri G, Spruss A, Wagnerberger S, et al. Role of tumor necrosis factor alpha (TNFalpha) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 2011; 22:527-534.
15. Pachikian BD, Essaghir A, Demoulin JB, et al. Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways. Mol Nutr Food Res 2013; 57:347-359.
16. Wagnerberger S, Spruss A, Kanuri G, et al. Lactobacillus casei Shirota protects from fructose-induced liver steatosis: A mouse model. J Nutr Biochem 2013; 24:531-538.
17. Kavanagh K, Wylie AT, Tucker KL, et al. Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr 2013; 98:349-35
18. Douard V, Ferraris RP. The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol 2013; 591 (Pt 2):401-414.
19. Walker RW, Le KA, Davis J, et al. High rates of fructose malabsorption are associated with reduced liver fat in obese African Americans. J Amer Coll Nutr 2012; 31:369-37
20. Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51:1961-1971.
21. Jin R, Le NA, Liu S, et al. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab 2012; 97:E1008-E109
22. Mager DR, Iniguez IR, Gilmour S, Yap J. The Effect of a Low Fructose and Low Glycemic Index/Load (FRAGILE) Dietary Intervention on Indices of Liver Function, Cardiometabolic Risk Factors, and Body Composition in Children and Adolescents With Nonalcoholic Fatty Liver Disease (NAFLD). J Parental Enteral Nutr 2013. [Epub ahead of print]
23. Vos MB, Weber MB, Welsh J, et al. Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: A pilot study. Arch Pediatr Adolesc Med 2009; 163:674-675.
24. Sevastianova K, Santos A, Kotronen A, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutri 2012; 96:727-73
25. Johnston RD, Stephenson MC, Crossland H, et al. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 2013; 145: 1016-102
26. Lanaspa MA, Ishimoto T, Li N, et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun 2013; 4:243
27. Hashemi Kani A, Alavian SM, Esmaillzadeh a. Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD). Hepat Mon 2013; 13:e10943.
28. Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500:585-58
29. Brown JM, Shelness GS, Rudel LL. Monounsaturated fatty acids and atherosclerosis: Opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep 2007; 9:494-500.
30. Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated with the severity of nonalcoholic fatty liver disease. Clin Nutr 2013. [Epub ahead of print]
31. Ryan MC, Itsiopoulos C, Thodis T, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with nonalcoholic fatty liver disease. J Hepatol 2013; 59:138-14
32. Di MinnoMN, Russolillo A, Lupoli R, et al. Omega-3 fatty acids for the treatment of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18:5839-5847.
33. Papandreou D, Karabouta Z, Pantoleon A, Rousso I. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without nonalcoholic fatty liver disease. Appetite 2012; 59:939-944.
34. St-Jules DE, Watters CA, Brunt EM, et al. Estimation of fish and omega-3 fatty acid intake in pediatric nonalcoholic fatty liver disease. J PediatrGastroenterol Nutr 2013; 57:627-633.
35. Janczyk W, Socha P, Lebensztejn D, et al. Omega-3 fatty acids for treatment of nonalcoholic fatty liver disease: Design and rationale of randomized controlled trial. BMC Pediatrics 2013; 13:85.
36. Kamisako T, Tanaka Y, Ikeda T, et al. Dietary fish oil regulates gene expression of cholesterol and bile acid transporters in mice.Hepatol Res 2012; 42:321-326.
37. Eckard C, Cole R, Lockwood J, et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: A randomized trial. Ther Adv Gastroenterol 2013; 6:249-25
38. DeVore S, Kohli R, Lake K, et al. A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD. J Pediatr Gastroenterol Nutr 2013; 57:119-12
39. Pacifico L, Arca M, Anania C, et al. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012; 23:1010-1016.